title: NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost.
authors.forename: Emily
authors.initials: E
authors.lastname: Underwood
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism* / Q000523:psychology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D061067:Antibodies, Monoclonal, Humanized / Q000187:drug effects* / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D003071:Cognition; D006801:Humans; D059906:Neuroimaging; D009488:Neurosciences
chemical_list: D016229:Amyloid beta-Peptides; D061067:Antibodies, Monoclonal, Humanized; C000600266:aducanumab; C550616:solanezumab